Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives
Patient Preference and Adherence · 2023-10 · Volume 17 · 2499-2516
DOI: 10.2147/ppa.s417677 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Patient Preference and Adherence, 2023-10. Verfasst von Yoshiya Tanaka und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
- Division of Immunology and Rheumatology, Stanford University, Stanford, CA, USA.
- Gilead Sciences, Inc, Foster City, CA, USA.
- Gilead Sciences, Inc, Tokyo, Japan.
ORCID-Profile: Yoshiya Tanaka, Mark C Genovese
Zitieren
APA
Tanaka, Y., Genovese, M. C., & Matsushima, H. (2023). Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives. Patient Preference and Adherence, Volume 17, 2499-2516. https://doi.org/10.2147/ppa.s417677
Vancouver
Tanaka Y, Genovese MC, Matsushima H. Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives. Patient Preference and Adherence. 2023;Volume 17:2499-2516. doi:10.2147/ppa.s417677
BibTeX
@article{Tanaka2023,
author = {Tanaka, Yoshiya and Genovese, Mark C and Matsushima, Hironori},
title = {Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives},
journal = {Patient Preference and Adherence},
year = {2023},
volume = {Volume 17},
pages = {2499--2516},
doi = {10.2147/ppa.s417677}
}
EUVIMED